Profile data is unavailable for this security.
About the company
Tonghua Dongbao Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of drugs. The Company provides biological products, traditional Chinese medicines and chemical supplements, applied in the treatment of diabetes and cardiovascular and cerebrovascular diseases. The Company's main products portfolio consists of recombinant human insulin bulk drugs and injections, zhennaoning capsules, and other products. The Company also provides medical instruments, plastic-steel windows and profiles, and engages in the real estate business. The Company distributes its products within domestic markets and to overseas markets.
- Revenue in CNY (TTM)2.74bn
- Net income in CNY1.23bn
- Incorporated1992
- Employees3.41k
- LocationTonghua Dongbao Pharmaceutical Co LtdDongbao New Village, Tonghua CountyTONGHUA 134123ChinaCHN
- Phone+86 4 355088025
- Fax+86 4 355088002
- Websitehttp://www.thdb.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Medicine Co Ltd | 8.96bn | 1.24bn | 15.52bn | 5.82k | 12.48 | 1.40 | -- | 1.73 | 1.29 | 1.29 | 9.31 | 11.50 | 0.6499 | 2.76 | 5.65 | 1,540,449.00 | 8.19 | 5.31 | 10.15 | 6.93 | 39.47 | 36.97 | 12.60 | 7.68 | 2.01 | -- | 0.0784 | 30.91 | 20.29 | 5.88 | 170.11 | 27.62 | 3.74 | -18.03 |
| Guobang Pharma Ltd | 5.94bn | 872.95m | 16.00bn | 4.00k | 18.23 | 1.93 | -- | 2.69 | 1.57 | 1.57 | 10.68 | 14.80 | 0.5603 | 3.06 | 7.04 | 1,484,531.00 | 8.20 | 9.52 | 10.33 | 12.47 | 24.67 | 27.10 | 14.64 | 14.91 | 2.30 | -- | 0.1038 | 24.76 | 10.12 | 9.15 | 27.61 | 19.94 | -7.08 | -- |
| China Resources Jingzhng Phrmctcl Co Ltd | 4.40bn | 837.30m | 16.01bn | 4.18k | 19.07 | 4.22 | -- | 3.64 | 1.32 | 1.32 | 6.94 | 5.98 | 0.6755 | 3.53 | 11.30 | 1,051,350.00 | 14.12 | 11.45 | 23.31 | 16.72 | 60.96 | 64.04 | 20.91 | 18.23 | 1.33 | -- | 0.0348 | 93.25 | -2.59 | 12.61 | 9.67 | 11.20 | 30.67 | 36.85 |
| Zhejiang Jiuzhou Pharmaceutical Co Ltd | 5.36bn | 722.87m | 16.02bn | 5.00k | 22.20 | 1.83 | -- | 2.99 | 0.8113 | 0.8113 | 6.07 | 9.84 | 0.493 | 1.97 | 4.84 | 1,070,948.00 | 6.65 | 9.23 | 7.91 | 12.19 | 34.65 | 33.78 | 13.50 | 15.64 | 2.42 | -- | 0.0152 | 39.55 | -6.57 | 20.67 | -41.34 | 20.58 | 22.64 | 8.45 |
| Nanjing King-Frind Bchmcl Phrmctcl C Ltd | 3.76bn | 649.83m | 16.22bn | 1.36k | 24.61 | 2.40 | -- | 4.31 | 0.4079 | 0.4079 | 2.35 | 4.18 | 0.3812 | 0.6322 | 3.82 | 2,765,677.00 | 6.59 | 8.38 | 8.99 | 12.03 | 41.12 | 44.95 | 17.28 | 19.72 | 1.35 | -- | 0.2644 | 23.22 | -0.1984 | 9.70 | 536.09 | 6.43 | 34.44 | -6.04 |
| Tonghua Dongbao Pharmaceutical Co Ltd | 2.74bn | 1.23bn | 17.37bn | 3.41k | 14.14 | 2.44 | -- | 6.34 | 0.6271 | 0.6271 | 1.40 | 3.64 | 0.3589 | 1.05 | 5.11 | 803,924.60 | 15.84 | 14.89 | 17.08 | 15.68 | 71.05 | 78.86 | 44.15 | 35.26 | 3.49 | -- | 0.0988 | 50.60 | -34.66 | -6.27 | -103.66 | -- | 14.17 | 4.56 |
| Jinyu Bio-Technology Co Ltd | 1.33bn | 100.76m | 17.53bn | 1.74k | 222.11 | 3.21 | -- | 13.21 | 0.071 | 0.071 | 1.27 | 4.92 | 0.1946 | 2.45 | 1.89 | 762,676.30 | 1.37 | 4.31 | 1.56 | 5.06 | 50.46 | 57.76 | 7.02 | 17.99 | 3.09 | -- | 0.0029 | 36.89 | -21.45 | 2.19 | -61.57 | -13.19 | -21.84 | -12.94 |
| Shandong Buchang Pharmaceuticals Co Ltd | 10.96bn | 1.66m | 18.29bn | 7.69k | 2,542.52 | 1.73 | -- | 1.67 | 0.0068 | 0.0068 | 10.34 | 10.03 | 0.5519 | 0.9196 | 13.73 | 1,425,409.00 | -0.6503 | 0.8521 | -0.9366 | 1.25 | 62.31 | 70.57 | -1.18 | 1.32 | 0.4929 | 3.23 | 0.2758 | 157.32 | -16.91 | -5.04 | -273.62 | -- | -21.53 | -- |
| Liaoning Cheng Da Co Ltd | 11.12bn | 862.79m | 18.54bn | 3.32k | 21.08 | 0.6302 | -- | 1.67 | 0.575 | 0.575 | 7.27 | 19.23 | 0.2277 | 5.72 | 5.88 | 3,352,748.00 | 2.94 | 3.15 | 4.13 | 4.55 | 12.07 | 13.95 | 12.89 | 9.88 | 0.9357 | -- | 0.2586 | 16.44 | 4.70 | -8.65 | -10.09 | -29.33 | -9.31 | -27.52 |
Data as of Feb 11 2026. Currency figures normalised to Tonghua Dongbao Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
6.56%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Abu Dhabi Investment Authority (Investment Management)as of 31 Mar 2025 | 32.00m | 1.60% |
| China Merchants Fund Management Co., Ltd.as of 31 Mar 2025 | 21.90m | 1.09% |
| China Southern Asset Management Co., Ltd.as of 31 Mar 2025 | 17.65m | 0.88% |
| Yinhua Fund Management Co., Ltd.as of 31 Mar 2025 | 17.38m | 0.87% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2025 | 10.82m | 0.54% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 7.99m | 0.40% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 6.33m | 0.32% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 6.21m | 0.31% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 5.91m | 0.30% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 5.27m | 0.26% |
More ▼
Data from 30 Jun 2025 - 02 Feb 2026Source: FactSet Research Systems Inc.
